Buy and Sell Pharmeasy Unlisted Shares Price Online

6 min read

PharmEasy is one of India’s leading online pharmacy platforms, offering easy access to medicines, healthcare products, and diagnostic services. As the company continues to expand its market presence, many investors are interested in its unlisted shares. 

Since PharmEasy is not yet publicly listed, its shares are traded in the unlisted market, where the PharmEasy share price fluctuates based on demand, financial performance, and investor interest. 

Before buying or selling these shares, it’s essential to understand PharmEasy’s business model, financial health, and the potential risks and benefits of investing in unlisted securities. 

This blog will walk you through everything you need to know about PharmEasy’s share price, financial performance, and the process of buying and selling them online, and it will conclude with the pros and cons of investing in its unlisted shares.

So, let's get started!

What is PharmEasy & Its Share Price?

PharmEasy, founded in 2015, is an Indian e-pharmacy platform that aims to make healthcare more accessible and affordable. 

  • It functions as a healthcare "super app," offering home delivery of medicines, diagnostic test services, and other healthcare products. 

  • The company, started by Dharmil Sheth and Dhaval Shah in Mumbai, now delivers medicines across 1,200+ cities in India, covering over 19,000 pin codes.

PharmEasy Share Price

As of February 14, 2025, PharmEasy’s unlisted share price is approximately ₹7.99 per share. The price of unlisted shares fluctuates based on demand and supply—higher demand pushes the price up, while lower demand brings it down.

(Source: Financial reports)

With an overview of PharmEasy and its share price in mind, let's take a closer look at the company’s financial data for deeper insights.

PharmEasy’s Financial Data: Insights and Analysis

The financial performance of PharmEasy as of February 12, 2025, reveals key metrics that reflect the company's current market standing and operational challenges. Below are the important details:

(Source: Financial reports)

Key Financial Indicators for FY24

Here are the key financial data for PharmEasy's unlisted shares in FY24:

(Source: Financial reports)

Now that you know about PharmEasy’s financial standing, let’s discuss how you can get started with buying its unlisted shares.

How to Buy PharmEasy Unlisted Shares?

Buying PharmEasy unlisted shares is easier than you might think. By following a few simple steps, you can quickly get started with purchasing shares through a trusted online platform like precize. Here are pointers to assist you through the process.

  1. Choose a Platform

The first thing you need to do is choose a trustworthy online platform that supports buying in unlisted stocks. In India, platforms like Precize are commonly used for such transactions as they offer a secure and reliable way to buy unlisted shares.

  1. Setup Your Account

Once you’ve selected your platform, visit the website on Precize to get started and click on the "Reserve Access" button on the website. 

This typically involves providing your basic information, including your full name, contact details, and necessary identity verification documents, such as your PAN card.

  1. Log In and Search

After your account is successfully set up, log in and search for PharmEasy unlisted shares. It’s crucial to do your research at this stage. Carefully review the share price as well as the company’s financial performance, including any reports or updates available. This will help you make an informed decision about your purchase.

  1. Decide How Many Shares to Buy

Next, decide how many shares you wish to buy, keeping in mind that platforms like Precize often have a minimum investment requirement, which is typically around ₹10,000. 

  1. Add Funds and Place Your Order

Then, you'll need to add funds to your account to proceed with the purchase. You can do this through a variety of payment options, including UPI, Net Banking, or other online methods supported by the platform, once you've added the necessary funds and placed your order.

  1. Confirmation and Transfer

After that, you will receive a confirmation notification via email or WhatsApp. The shares will be transferred to your depository account (CDSL/NSDL) within 24-48 business hours, provided that your Demat account details are accurate. This completes the process, and you now own PharmEasy unlisted shares in your Demat account.

After you’ve bought PharmEasy unlisted shares, selling them can be just as straightforward. Let’s explore how.

How to Sell PharmEasy Unlisted Shares?

When it comes to selling your PharmEasy unlisted shares, the process can be made easy with the right platform. 

  • Start by choosing a trusted platform like Precize, known for secure and efficient transactions in India. 

  • Precize can help you liquidate your unlisted shares by facilitating a buyer in 24-48 business hours. 

  • Throughout the process, the platform's expert team will provide guidance, ensuring everything runs smoothly.

Conclusion

PharmEasy is a major player in the Indian healthcare market, offering services like online medicine delivery and diagnostic testing. As we’ve seen, PharmEasy's share price for its unlisted shares reflects both opportunities and challenges, with potential growth tempered by financial risks. However, the nature of unlisted shares means that liquidity and transparency remain key concerns for investors.

But with Pecize, you don’t need to worry about these complexities. Pecize provides a simple, secure platform for buying and selling unlisted shares, including PharmEasy. With a low investment threshold of ₹10,000, Pecize makes it easy for you to get started. 

The platform offers insights into past price performance, including PharmEasy share price trends, and keeps you updated with the latest market news. Using Pecize, you can diversify your portfolio and stay informed about unlisted companies with ease. 

So, reserve your access today!

Disclaimer

The information provided in this blog is for informational purposes only and should not be considered financial advice. Investing in unlisted shares, including PharmEasy's unlisted shares, involves risk and may not be suitable for all investors. The value of these shares may fluctuate, and there is no guarantee of future performance. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. 

Precize
Precize
Content Strategy and Research Analyst

Stay in the Loop

Join our newsletter for exclusive access to thoughtfully curated content and we promise, no spam

The next generation of asset classes in India

Resources

Our Office

Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093

Find us on Google

support@precize.in

+91 7738336457

All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.

The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.

Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.

The website will be updated regularly.

Copyright © 2026 - Precize - All Rights Reserved